Paul Scheel

Dr. Paul Scheel

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2024 in International Journal of Cardiology
Verified
Journal Article
Closed access
PSPaul Scheel
Paul Scheel
ICIside Cartella
Iside Cartella
BMBrittney Murray
Brittney Murray
NGNisha A. Gilotra
Nisha A. Gilotra
EAEnrico Ammirati
Enrico Ammirati

24 December 2021 in ESC Heart Failure
Verified
Journal Article
Open access
PDF file
PSPaul Scheel
Paul Scheel
KGKatherine Giuliano
Katherine Giuliano
CTCrystal Tichnell
Crystal Tichnell
CJCynthia James
Cynthia James
BMBrittney Murray
Brittney Murray
AKAhmet Kilic
Ahmet Kilic
Aims End-stage heart failure necessitating evaluation for heart transplantation is increasingly recognized in arrhythmogenic right ventricular cardiomyopathy (ARVC). These patients present unique challenges in pre-transplant and peri-transplant management given their predominantly right ventricular (RV) failure and propensity for ventricular arrhythmias. We sought to utilize a tertiary ARVC referral and heart transplant centre experience to describe management of a series of patients with ARVC undergoing heart transplantation at our centre. Methods and results We queried the Johns Hopkins ARVC Registry for all patients who underwent heart transplantation and further studied the subset undergoing transplantation at the Johns Hopkins Hospital. Patient demographics, clinical characteristics, and pre-transplant clinical course were obtained from the registry and electronic medical records. Of the 532 patients in the ARVC Registry, 63 (12%) underwent heart transplantation. Nine (six male) of these patients both had known ARVC prior to transplant and were transplanted at Johns Hopkins Hospital between 2006 and 2020 at a mean age of 42 ± 14 years old. Pathogenic ARVC genetic variants were identified in six (67%) patients, all of whom had variants in the plakophilin-2 (PKP2) gene. RV failure was universal with median right atrial to pulmonary capillary wedge pressure (RA/PCWP) ratio of 1.4 [interquartile range (IQR) 1.2–1.5] and median right ventricular stroke work index (RVSWI) of 0 g·m/m2/beat (IQR 0–0.3). Six had a history of catheter ablation for ventricular arrhythmia with five of the six having at least three ablations. Transplant evaluation was initiated an average of 344 ± 407 days after first developing heart failure symptoms. The most common bridge to transplant support included inotropes (n = 3) and extracorporeal membrane oxygenation (ECMO) (n = 2). Contraindication to inotropes or mechanical support was common due to ventricular arrhythmia and RV predominant cardiomyopathy. Conclusions Heart transplantation is a curative treatment for ARVC, but due to frequent ventricular arrhythmias and RV predominant pathology, patients require unique considerations in regard to timing of evaluation, haemodynamic support options, and wait listing qualification.

9 December 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
YMYash Maniar
Yash Maniar
NGNisha A. Gilotra
Nisha A. Gilotra
PSPaul Scheel
Paul Scheel
Improved disease recognition through family screening and increased life expectancy with appropriate sudden cardiac death prevention has increased the burden of heart failure in arrhythmogenic cardiomyopathy (ACM). Heart failure management guidelines are well established but primarily focus on left ventricle function. A significant proportion of patients with ACM have predominant or isolated right ventricle (RV) dysfunction. Management of RV dysfunction in ACM lacks evidence but requires special considerations across the spectrum of heart failure regarding the initial diagnosis, subsequent management, monitoring for progression, and end-stage disease management. In this review, we discuss the unique aspects of heart failure management in ACM with a special focus on RV dysfunction.

19 March 2026 in Transplant Infectious Disease
Verified
Journal Article
Closed access
PDF file
ASAlison M. Samsel
Alison M. Samsel
SSSara Strout
Sara Strout
RARobin K. Avery
Robin K. Avery
EBErrol L. Bush
Errol L. Bush
MDM. Veronica Dioverti
M. Veronica Dioverti
BLBrian K. Lindner
Brian K. Lindner

12 December 2025 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
PSPaul Scheel
Paul Scheel
SHSteven Hsu
Steven Hsu

28 April 2022 in Journal of Cardiac Failure
Verified
Journal Article
Closed access
PSPaul Scheel
Paul Scheel
KGKatherine Giuliano
Katherine Giuliano
BMBrittney Murray
Brittney Murray
CTCrystal Tichnell
Crystal Tichnell
CJCynthia James
Cynthia James
AKAhmet Kilic
Ahmet Kilic